Photo from wikipedia
Remimazolam, an ultra‐short‐acting benzodiazepine, has been used for procedural sedation in the United States. We conducted an investigator‐initiated clinical trial to determine the appropriate dose of remimazolam required for sedation… Click to show full abstract
Remimazolam, an ultra‐short‐acting benzodiazepine, has been used for procedural sedation in the United States. We conducted an investigator‐initiated clinical trial to determine the appropriate dose of remimazolam required for sedation during gastrointestinal endoscopy in Japanese subjects.
Keywords:
endoscopy;
gastrointestinal endoscopy;
investigator initiated;
clinical trial;
initiated clinical
Journal Title: Digestive Endoscopy
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Digestive Endoscopy
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!